JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202992200 on April 2, 2002

J. Biol. Chem., Vol. 277, Issue 23, 20750-20755, June 7, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/23/20750    most recent
M202992200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strack, S.
Right arrow Articles by Cribbs, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strack, S.
Right arrow Articles by Cribbs, J. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Protein Phosphatase 2A Holoenzyme Assembly

IDENTIFICATION OF CONTACTS BETWEEN B-FAMILY REGULATORY AND SCAFFOLDING A SUBUNITS*

Stefan StrackDagger §, Ralf Ruediger, Gernot Walter, Ruben K. DagdaDagger , Chris A. BarwaczDagger , and J. Thomas CribbsDagger

From the Dagger  Department of Pharmacology, University of Iowa, Iowa City, Iowa 52242 and  Department of Pathology, University of California at San Diego, La Jolla, California 92093

Received for publication, March 27, 2002, and in revised form, March 29, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Protein serine/threonine phosphatase (PP) 2A is a ubiquitous enzyme with pleiotropic functions. Trimeric PP2A consists of a structural A subunit, a catalytic C subunit, and a variable regulatory subunit. Variable subunits (B, B', and B" families) dictate PP2A substrate specificity and subcellular localization. B-family subunits contain seven WD repeats predicted to fold into a beta -propeller structure. We carried out mutagenesis of Bgamma to identify domains important for association with A and C subunits in vivo. Several internal deletions in Bgamma abolished coimmunoprecipitation of A and C subunits expressed in COS-M6 cells. In contrast, small N- and C-terminal Bgamma deletions had no effect on incorporation into the PP2A heterotrimer. Thus, holoenzyme association of B-family subunits requires multiple, precisely aligned contacts within a core beta -propeller domain. Charge-reversal mutagenesis of Bgamma identified a cluster of conserved critical residues in Bgamma WD repeats 3 and 4. Acidic substitution of paired basic residues in Bgamma (RR165EE) abolished association with wild-type A and C subunits, while fostering incorporation of Bgamma into a PP2A heterotrimer containing an A subunit with an opposite charge-reversal mutation (EE100RR). Thus, binding of A and B subunits requires electrostatic interactions between conserved pairs of glutamates and arginines. By expressing complementary charge-reversal mutants in neuronal PC6-3 cells, we further show that holoenzyme incorporation protects Bgamma from rapid degradation by the ubiquitin/proteasome pathway.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The balance of protein kinase and phosphatase activities toward key proteins is central to many aspects of cellular physiology. Compared with kinases, protein phosphatases have received little attention, and appreciation that they may be just as precisely regulated as the enzymes whose action they oppose is relatively recent.

PP2A1 is one of the four major classes of serine/threonine phosphatases that also include PP1, PP2B (calcineurin), and PP2C. PP2A is highly conserved in eukaryotes (for recent reviews, see Refs. 1 and 2). It constitutes between 0.3% and 1% of total protein in mammalian cells (3, 4) and supplies the majority of soluble phosphatase activity toward phospho-serine and -threonine. PP2A is a holoenzyme of two or three subunits. A 36-kDa catalytic or C subunit complexes with a 65-kDa scaffolding A subunit to form the AC core enzyme; the core enzyme can bind a third, variable subunit to form the PP2A heterotrimer. In mammals, A and C subunits are each encoded by two highly similar genes (Aalpha /beta and Calpha /beta ), with Aalpha and Calpha isoforms being more abundant. Regulatory subunits are encoded by three multigene families referred to as B, B', and B". The B family (also known as PR55) consists of four genes, Balpha , Bbeta , Bgamma , and Bdelta , that give rise to proteins with molecular masses of 54-57 kDa (5-9). The B' family (also referred to as B56 or PR61) consists of at least seven isoforms encoded by five genes (B'alpha , B'beta , B'gamma , B'delta , and B'epsilon ) (10-15), with molecular masses between 54 and 74 kDa. The four known members of the B" family are designated according to their masses as PR48 (16), PR59 (17), and PR72/130 (18). Several PP2A regulatory subunits show restricted tissue expression; for instance, Bbeta and Bgamma can only be detected in brain (6, 19). Proteins encoded by DNA tumor viruses, SV40 small t and polyoma virus small and middle T antigen, are a fourth group of proteins that bind to the PP2A core enzyme and subvert its activity as a suppressor of cellular transformation (20-22). The AC dimer has also been shown to interact with other proteins, including the WD repeat-containing proteins striatin and SG2NA (23).

Evidence is accumulating that regulatory subunits impart specific functions to PP2A holoenzymes (24, 25). For example, B-family regulatory subunits have been implicated in the regulation of cytoskeletal protein assembly (26-28), B' subunits participate in the developmental Wnt/beta -catenin signal transduction cascade (29, 30), and B" subunits may control the G1-S cell cycle transition (16, 17). Adenovirus type 5 appears to induce apoptosis by interaction of its E4orf4 protein with the Balpha subunit of PP2A (31, 32). How regulatory subunits function to mediate the diverse physiological functions of PP2A is poorly understood. There is in vitro evidence that regulatory subunits affect enzymatic activity and substrate specificity of PP2A (33). Localization studies have suggested that regulatory subunits target PP2A holoenzymes to distinct subcellular compartments (11, 14, 19).

The crystal structure of the scaffolding Aalpha subunit of PP2A has been solved (34), confirming a previous model based on secondary structure prediction and mutagenesis studies (35). The A subunit is a hook-shaped protein made up almost entirely of 15 imperfect repeats, each about 40 amino acids long. Each of these HEAT repeats (named after proteins that contain them: huntingtin, elongation factor, A subunit, and TOR kinase) consists of two antiparallel, amphipathic alpha -helices. Loops between the two helices (intrarepeat loops) form a continuous ridge along the inside of the hook, providing interaction surfaces for catalytic and regulatory subunits. Regulatory subunits and viral antigens bind to the 10 N-terminal repeats, whereas the catalytic subunit binds via repeats 11-15 (35, 36). The PP2A C subunit is thought to have a roughly globular structure similar to that of the related PP1 C subunit (37, 38).

Knowing how regulatory subunits fold and interact with the core PP2A dimer is crucial for our understanding of the diverse roles of PP2A in cells. Here, we carry out deletion and site-directed mutagenesis in combination with structure modeling to identify domains and amino acids important for holoenzyme association of B-family regulatory subunits. By complementary charge-reversal mutagenesis, we show that adjacent arginines in Bgamma critically interact with adjacent glutamates in the Aalpha subunit.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Structure Modeling-- An amino acid alignment of B-family regulatory subunits from different phyla was submitted to the 3D-PSSM protein fold recognition web server (39), which generated a first-round model based on the structure of the Gbeta 1 subunit of heterotrimeric G proteins (40). This model was globally and locally optimized for bond lengths, angles, and torsions of side chains using the steepest decent algorithm of the Swiss PDB Viewer software (41). In addition, breaks in the Calpha trace were ligated with a cutoff value of 3.0 Å, and missing hydrogen atoms were added to the model. Ribbon diagrams and surface representations of the optimized B subunit model were rendered, annotated, and analyzed using Rasmol and Swiss PDB Viewer software.

Mutagenesis-- The rat cDNA for Bgamma was isolated by reverse transcription-PCR from rat brain total RNA (Access reverse transcription-PCR kit; Promega, Madison, WI), subcloned into a pcDNA3.1 mammalian expression vector under control of the cytomegalovirus promoter, and FLAG epitope tagged at the N terminus by PCR.

The Bgamma Delta 26-38 and Delta 379-447 mutants were generated by restriction digestion of the wild-type plasmid with uniquely cutting restriction enzymes, followed by fill-in and recircularization reactions. The Bgamma Delta 1-20 N-terminal truncation mutant was generated by PCR amplification of the coding sequence with nested primers encoding the FLAG tag and amino acids 21-25 of Bgamma .

Generation of internal deletion mutants involved PCR amplification of two halves of the Bgamma cDNA-containing plasmid, one extending from the 5' end of the deletion to approximately halfway around the plasmid, and the other extending from the 3' deletion boundary to the same site in the vector backbone in the opposite direction. Reverse primers annealing to sequences 5' of the deletion and forward primers annealing to 3' deletion boundaries also included a unique SacII site encoding a neutral "stuffer" sequence (Ala, Ala-Ala, or Ala-Ala-Gly), and complementary forward and reverse primers annealing to the plasmid backbone introduced a unique AscI site. PCR-generated plasmid halves were digested with SacII and AscI and ligated to produce the complete plasmid carrying the deletion.

The Bgamma Delta 434-447 and Delta 440-447 C-terminal truncation mutants were generated by site-directed mutagenesis of residues 434 and 440, respectively, to termination codons. Site-directed mutagenesis was carried out by whole-plasmid synthesis with complementary primers harboring mutations utilizing Pfu Turbo polymerase (Stratagene), followed by destruction of the template plasmid by digestion with DpnI. All mutations were verified by automated sequencing. All Aalpha subunit plasmids have been described previously (42).

Transfection and Immunoprecipitation-- COS-M6 cells (43) were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and 4.5 g/liter glucose and seeded into 6-well plates for transfection on the next day at ~80% confluence. Cells were transfected with 4 µl of LipofectAMINE 2000 (Invitrogen) and 2 µg of plasmid DNA. Aalpha and Bgamma subunits plasmids were cotransfected at 1:1 mass ratios. After 36-48 h, cells were rinsed once with phosphate-buffered saline, lysed in 250 µl/well immunoprecipitation buffer (1% Triton X-100, 150 mM NaCl, 20 mM Tris, pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mM beta -glycerolphosphate, 1 mM Na3VO4, 1 mM Na4P2O7, 1 µM microcystin-LR, 1 mM phenylmethylsufonyl fluoride, 1 µg/ml leupeptin, and 1 mM benzamidine), and sonicated for 2 s at low intensity with a probe tip sonicator. Debris was pelleted (20,000 × g, 15 min), and FLAG-tagged Bgamma subunits were immunoprecipitated from the cleared lysate with 6 µl of anti-FLAG tag antibody (M2) conjugated to agarose (Sigma) by end-over-end rotation at 4 °C for 3-16 h. In some experiments, 200 µg/ml FLAG epitope peptide was added to the cleared lysate as a specificity control. Immunoprecipitates were washed with 6-8 ml of immunoprecipitation buffer and solubilized in SDS sample buffer for immunoblot analysis using the following antibodies: rabbit anti-FLAG tag (Affinity Bioreagents, Golden, CO), mouse anti-EE tag (Babco, Richmond, CA), mouse anti-PP2A catalytic subunit (BD PharMingen), and rabbit anti-ubiquitin (Novocastra, Newcastle, UK). Blots were processed for chemiluminescence detection (Pierce SuperSignal, Pierce, New York, NY), and digital images were captured on a Kodak Imaging Station 440. Signal intensities were quantified by digital densitometry using National Institutes of Health Image software (rsb.info.nih.gov/nih-image/).

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Structure Prediction of PP2A B-family Regulatory Subunits-- Mammalian B-family regulatory PP2A subunits (Balpha -delta ) display high degrees of sequence conservation (>80% amino acid identity). Secondary structure prediction suggests that B-family regulatory subunits are almost entirely composed of beta -sheets and turns, whereas the B' and B" subunits are mostly alpha -helical. Thus, PP2A regulatory subunit families have distinct primary and secondary structures. As has been noted previously (44), B-family regulatory subunits contain several degenerate WD repeats (four to seven, depending on the isoform and motif search threshold). WD (also called WD40 or Gbeta ) repeats are loosely defined, ~40-amino acid sequence motifs that often end with the tryptophan-aspartate (WD) dipeptide (45). The amino acid sequence of Bgamma , a representative member of the B subunit family, aligned by WD repeat motifs is shown in Fig. 1A. Seven degenerate WD repeats are separated by regions of 13-46 residues in length (c-d loops).


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 1.   Structure prediction of B-family regulatory subunits. A, the amino acid sequence of Bgamma was aligned according to boundaries of the seven WD repeats and component beta -strands (d and a-c) provided by the Pfam web application (pfam.wustl.edu; Ref. 54). Sequence conservation of WD repeats is indicated by gray and black shading. B, schematic of beta -strand arrangement of the beta -propeller fold, highlighting the phase-shift of WD repeats (identified by shading) and propeller blades. C, ribbon view of the B subunit model based on the Gbeta 1 crystal structure; note that the large loops connecting WD repeats (c-d loops) were not completely modeled.

The two WD repeat-containing proteins whose three-dimensional structure has been solved to date are the Gbeta 1 subunit of heterotrimeric G proteins (40) and the p40 subunit of the arp2/3 actin filament branching complex (p40-ARC; Ref. 46). Both proteins fold into a seven-bladed beta -propeller, a toroid structure in which seven twisted, antiparallel beta -sheets are radially arranged around a common center. Each WD repeat contributes the outer (d) beta -strand of one propeller blade and the inner three beta -strands (a-c) of the next propeller blade (Fig. 1B). This phase-shift of sequence and structural motifs allows for closure of the torus by a "velcro" mechanism (45). Sequences preceding the first WD repeat and trailing the last repeat may protrude from the core toroid (Fig. 1B).

Three web-based threading protein fold prediction algorithms (3D-PSSM (39), FUGUE (47), and 123D (genomic.sanger.ac.uk/123D/123D.html)) identified Gbeta 1 as the closest structural homolog of PP2A B-family regulatory subunits, despite low sequence similarity (~15% identity). The structure of B-family regulatory subunits was modeled based on the Gbeta 1 crystal structure (see "Experimental Procedures"). A ribbon diagram of this model shows the seven-bladed beta -propeller fold characteristic of WD repeat-containing proteins (Fig. 1C). Because PP2A B-family regulatory subunits are larger than Gbeta 1, portions of the larger loops connecting WD repeats are missing from the model.

Deletion Mutagenesis-- To define regions and residues in B-family regulatory subunits critical for association with the AC core dimer, we carried out deletion and site-directed mutagenesis of the Bgamma coding sequence. Mutant Bgamma cDNAs carrying an N-terminal FLAG epitope tag were transiently expressed in COS-M6 cells in combination with the scaffolding Aalpha subunit tagged with a C-terminal EE epitope (42). FLAG-Bgamma was immunoprecipitated and washed extensively, and in vivo incorporation into the PP2A heterotrimer was assayed by blotting Bgamma immunoprecipitates for transfected Aalpha and endogenous C subunits. The ability of Bgamma mutants to associate with the core enzyme was quantified by densitometry as the ratio of C to Bgamma subunit bands in the same lane. In general, mutating Bgamma affected Aalpha and C subunit binding to similar degrees, supporting the notion that regulatory subunits interact with a structural unit of A and C subunits. A schematic diagram of the Bgamma deletion and truncation mutants is shown in Fig. 2A.


View larger version (62K):
[in this window]
[in a new window]
 
Fig. 2.   Mapping the holoenzyme association domains of Bgamma by deletion mutagenesis. Wild-type (w.t.) FLAG-tagged Bgamma , the diagrammed deletion mutants (A), or vector alone was transiently expressed in COS-M6 cells, immunoprecipitated (IP), and tested for association with cotransfected Aalpha subunit (EE epitope-tagged) and endogenous C subunit by immunoblotting. A representative immunoblot is shown in B; the broad band below the Aalpha subunit band is immunoglobulin heavy chain. Coimmunoprecipitated C subunit (C coIP) was quantified as the ratio of C to Bgamma subunit in each lane and is listed relative to wild-type Bgamma below the blot (average of two to four independent experiments).

B subunit family members differ considerably in their first 20-30 residues. Deletion of the variable 20 N-terminal amino acids of Bgamma (Delta 1-20) had little effect on binding to the A and C subunit (Fig. 2B), consistent with a role of these residues in mediating isoform-specific functions. This deletion extends into the predicted first (d) beta -strand of WD repeat 1, which, according to the crystal structures of Gbeta 1 and p40-ARC, is critical for closure of the beta -propeller core by interacting with the c-strand of WD repeat 7 (see Fig. 1B). It is conceivable that the FLAG epitope tag can substitute for the 5 residues deleted from WD repeat 1; alternatively, the boundaries of this structural motif in Bgamma may require revision.

At the C terminus, truncating the 8 amino acids that follow the last WD repeat in Bgamma (Delta 440-447) had no effect on holoenzyme association. Extending the truncation by just 6 amino acids (Delta 434-447) to include the predicted c-strand of WD repeat 7 caused an almost complete loss of A and C subunit binding. Thus, residues 434-439 are required for holoenzyme association, presumably because they interact with N-terminal residues to maintain the toroid structure of Bgamma .

Four internal deletions throughout the Bgamma protein ranging from 12 to 32 residues in length completely abrogated coimmunoprecipitation of A and C subunits (3-7% of wild-type); only the Delta 381-401 deletion displayed close to wild-type binding activity (Fig. 2B). Three of these critical deletions (Delta 128-156, Delta 259-270, and Delta 370-401) are predicted to affect surface-exposed loops connecting WD repeats, whereas Delta 26-38 deletes a portion of WD repeat 1 predicted to be buried in the protein. The apparent intolerance of the Bgamma core (residues 21-439) to small deletions suggests that the interaction of B-family subunits with the AC dimer requires precise alignment of multiple interacting residues.

Charge-reversal Mutagenesis-- Site-directed mutagenesis was carried out to delineate specific sites of holoenzyme interaction. All Bgamma residues that were mutated are perfectly conserved in other mammalian B-family isoforms and their orthologs in worms, fruit flies, and yeast. Carrying out similar mutagenesis experiments with the Aalpha subunit, we had previously identified charged residues in HEAT repeats 3 (Glu100 and Glu101) and 5 (Arg183) important for binding to regulatory subunits and viral tumor antigens (42). Hence, we focused the Bgamma mutagenesis on charge-reversal of basic and acidic residues with the goal of identifying electrostatic interactions with the Aalpha subunit.

Three acidic-to-basic mutations of conserved residues in the N-terminal third of Bgamma (E66R, EE89RR, and D112K) had no effect on holoenzyme association (Fig. 3). In contrast, four Bgamma mutants in WD repeat 3 (RR165EE, D184K, E186R, and DD192RR) and two mutants in the loop connecting WD repeat 3 and WD repeat 4 (D212K and IK213EE) displayed severely reduced binding to A and C subunits (between 2% and 12% of wild-type). Mapping to WD repeat 4, Bgamma mutant ED219RR incorporated into the PP2A holoenzyme normally, whereas E223R was defective. Because Bgamma Delta 259-270 was binding-incompetent (Fig. 2B), we tested the effect of mutating all acidic residues in this region. Bgamma D259R did not bind to the AC dimer, whereas Bgamma EE266RR, E269R, and D270R had little or no effect on the ability of Bgamma to associate with A and C subunits. Lastly, the E343R mutation in WD repeat 6 had an intermediate effect on the ability of Bgamma to incorporate into the PP2A heterotrimer (40% residual binding of the C subunit; Fig. 3).


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 3.   Identification of Bgamma residues important for holoenzyme association. A, wild-type (w.t.) FLAG-tagged Bgamma , the indicated site-directed mutants, or empty vector was expressed in COS-M6 cells and tested for association with transfected Aalpha (EE-tagged) and endogenous C subunits by coimmunoprecipitation (coIP). The percentage binding of the C subunit was quantified as described in the Fig. 2 legend and is shown as the average of two to five experiments. B, summary of Bgamma deletion and site-directed mutagenesis results. Critical mutations displaying <15% wild-type C subunit binding activity are indicated on the top of the domain diagram; noncritical mutations (>= 40% wild-type binding) are indicated on the bottom of the domain diagram.

The results of the deletion and site-directed mutagenesis experiments are summarized in Fig. 3B. Bgamma mutants were classified as critical or noncritical depending on the amount of coimmunoprecipitated C subunit (<15% and >= 40% of wild-type, respectively). Most critical amino acid substitutions cluster in the middle of the molecule (165-259) encompassing WD repeats 3 and 4.

Li and Virshup (48) have recently reported that two fragments of B'alpha can bind to the Aalpha subunit in glutathione S-transferase pull-down assays. Intriguingly, the corresponding regions in Balpha and B"/PR72 also interacted with Aalpha , even though PP2A regulatory subunit families display little primary amino acid similarity and are classified into different structural families according to protein fold prediction algorithms (39, 47). The N-terminal "A subunit binding domain" defined by Li and Virshup corresponds to Bgamma residues 172-270, a region that we show here contains many residues necessary for holoenzyme association in vivo. The C-terminal A subunit binding domain encompasses Bgamma residues 302-360. We mutated E343 in this region, which, according to Li and Virshup's domain alignment (48), is invariant in B, B', B" subunits, and we observed an intermediate effect on PP2A holoenzyme formation.

Identification of Interacting Residues-- We speculated that evolutionarily conserved and surface-exposed, charged residues of Bgamma interact with residues of opposite charge in Aalpha that we previously identified as critical for regulatory subunit association (Glu100, Glu101, and Arg183; Ref. 42). Consequently, we coexpressed charge-reversal mutants of the Aalpha subunit (EE100RR and R183E) with all opposite charge-reversal mutants of the Bgamma subunit and tested for complementation, i.e. restoration of holoenzyme assembly by coimmunoprecipitation. We were unable to show association of any of the acidic-to-basic mutants of Bgamma with the basic-to-acidic mutant Aalpha R183E (data not shown). There are three potential reasons for this: 1) we may have not mutated the interacting residue in Bgamma , 2) Aalpha or Bgamma mutations, while potentially affecting interacting residues, may introduce structural changes that misalign other important amino acids, and 3) Aalpha R183 may not interact directly with regulatory subunits.

However, when we paired Aalpha EE100RR with Bgamma RR165EE, we observed binding that was comparable to wild-type subunits (Fig. 4). Bgamma RR165EE was unable to coimmunoprecipitate another binding-defective, acidic-to-basic Aalpha mutant, DW139RR (data not shown), demonstrating that the observed complementation is not a consequence of altering the overall charge of the proteins. Thus, PP2A holoenzyme association is critically dependent on electrostatic interactions between adjacent glutamates in the A subunit (Glu100 and Glu101 in Aalpha ) and adjacent arginines in B-family regulatory subunits (Arg165 and Arg166 in Bgamma ). Because the EE100RR mutation in Aalpha interferes with binding of all regulatory subunit families (42), it is likely that B' and B" subunits also interact via basic residues. We reversed the charge of a pair of conserved lysine residues in B'epsilon that is in a position similar to Bgamma Arg165 and Arg166 (B'epsilon KK173DD), but this mutation did not disrupt PP2A holoenzyme assembly (data not shown). Additional studies are necessary to identify points of contact between Aalpha and B'/B" subunits.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 4.   Identification of interacting residues in Bgamma and Aalpha . Wild-type (w.t.) or mutant FLAG-tagged Bgamma and EE-tagged Aalpha subunits were coexpressed in the indicated combinations in COS-M6 cells and tested for association by FLAG immunoprecipitation, followed by immunoblotting for PP2A subunits.

Monomeric Bgamma Is Degraded by the Ubiquitin/proteasome Pathway-- All Bgamma mutants could be expressed to similar, high levels in COS-M6 cells, a cell line that supports plasmid replication due to expression of the SV40 large T antigen. Studying the effects of Bgamma mutants in the neuronal PC6-3 subline of PC12 cells (49), in which much lower levels of expression can be achieved, we noticed that holoenzyme formation-defective mutants could be expressed to at most 10% of wild-type Bgamma levels. This is shown for two mutants in Fig. 5A. Importantly, expression levels of Bgamma RR165EE, but not D212K, could be rescued by coexpression of the complementary Aalpha EE100RR mutant, indicating that low expression is a consequence of failure to incorporate into the PP2A holoenzyme. To investigate the mechanism of this effect, PC6-3 cells were treated with the proteasome inhibitor MG-132 for 2 h before immunoblotting. Proteasome inhibition resulted in a massive increase of Bgamma protein levels but had no effect on levels of another transfected protein (calcium/calmodulin-dependent protein kinase IIalpha ) or the endogenous PP2A C subunit (Fig. 5B). MG-132 treatment led to the accumulation of higher molecular weight species of Bgamma D212K that were immunoreactive for ubiquitin (Fig. 5C). Similar results were obtained with the RR165EE mutant and wild-type Bgamma .


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 5.   Ubiquitination and proteasome-mediated degradation of monomeric Bgamma subunits in PC6-3 cells. A, the indicated combinations of wild-type (w.t.) and mutant Bgamma and Aalpha subunits (ER, EE100RR) were transiently expressed in PC6-3 cells, and total lysates were immunoblotted for Bgamma (FLAG tag) and the endogenous C subunit. B, indicated Bgamma mutants or the alpha  isoform of calcium/calmodulin-dependent protein kinase II (CaMKIIalpha ) were expressed in PC6-3 cells and treated for 2 h before lysis without (-) or with (+) the proteasome inhibitor MG-132 (50 µM). Total lysates were immunoblotted for the indicated proteins. C, FLAG-Bgamma D212K was transfected and immunoprecipitated from PC6-3 cells treated for 6 h in the absence or presence of 50 µM MG-132. Aliquots of immunoprecipitates were blotted for the FLAG tag (left) and ubiquitin (right). To account for increased levels of Bgamma after MG-132 treatment, twice the volume of the control immunoprecipitate was analyzed. The distributions of high molecular weight FLAG tag and ubiquitin immunoreactivities do not correspond well because of the disproportion of ubiquitin and FLAG epitopes in larger Bgamma species.

It was previously shown that transfected B' subunits quantitatively incorporate into the PP2A holoenzyme (11) and that ablation of PP2A A or C subunits by RNA interference decreases the stability of regulatory subunits in Drosophila Schneider cells (25). The present results provide further evidence that PP2A subunit expression levels are stringently controlled in cells and suggest ubiquitination and proteasome-mediated degradation as a mechanism for rapid removal of monomeric regulatory subunits.

Structure modeling and site-directed mutagenesis support the model of PP2A holoenzyme structure shown in Fig. 6. B-family regulatory subunits adopt a beta -propeller fold that is found in other proteins engaged in multiple protein-protein interactions (40, 46). By mutational complementation, we identified electrostatic interactions between two conserved arginines in the outer (d) strand of WD repeat 3 of Bgamma and two glutamates in the intrarepeat loop of HEAT repeat 3 of Aalpha . Previous domain mapping and site-directed mutagenesis of the A subunit (35, 36, 42) and the present data argue for multiple additional contacts between regulatory and scaffolding subunits. Also, regulatory subunit binding to the AC dimer is likely stabilized by direct interactions between B and C subunits, possibly involving the carboxyl-methylated C terminus of the C subunit (50-53). Critical amino acids in Bgamma are located C-terminal of the A subunit-contacting residues Arg165 and Arg166 and cluster in WD repeats 3 and 4 and the intervening loop. We propose that this region forms extensive contacts with the intrarepeat loops of HEAT repeats 4-7 of the Aalpha subunit, where many residues important for regulatory subunit binding are localized (42). Consistent with possible isoform-specific functions, we find that the divergent N-terminal tail of Bgamma is expendable for intersubunit interactions. Instead, N-terminal residues of B-family regulatory subunits may determine the subcellular localization of PP2A holoenzymes by interacting with specific anchoring proteins (19). Compatible with this view, the Bgamma N terminus faces away from the A subunit in our PP2A holoenzyme model. This report addresses the structural basis of PP2A holoenzyme function but requires ultimate verification and refinement by other methods such as crystallography.


View larger version (74K):
[in this window]
[in a new window]
 
Fig. 6.   Model of the PP2A holoenzyme. A space-filling representation of the structure of the Aalpha subunit (34) is arranged with model structures of the C and Bgamma subunits (based on the PP1 catalytic subunit (38) and Gbeta 1 (40), respectively; see the text). Residues whose mutation disrupts subunit association (critical) are indicated in black; interacting residues are colored green. Arg183 (R183) and Trp257 (W257) are highlighted as representative of several critical residues in HEAT repeats 5 and 7 of the Aalpha subunit (42). Some critical Bgamma residues are not shown because they are either absent from the model (Lys214 and Asp259) or are buried (Asp192).


    ACKNOWLEDGEMENTS

We thank Nancy Lill for advice on the proteasome experiments and gifts of MG-132 and ubiquitin antibody, Henry Paulson for PC6-3 cells, Raul Dagda for technical assistance, and John Koland for comments on the manuscript.

    FOOTNOTES

* This work was supported by funds from the Department of Pharmacology and the Biosciences Initiative of the University of Iowa and by seed grants from the Diabetes and Endocrinology Research Center (DK25295) and the College of Medicine.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Pharmacology, University of Iowa College of Medicine, 2-432 BSB, 51 Newton Rd., Iowa City, IA 52242. Tel.: 319-384-4439; Fax: 319-335-8930; E-mail: stefan-strack@uiowa.edu.

Published, JBC Papers in Press, April 2, 2002, DOI 10.1074/jbc.M202992200

    ABBREVIATIONS

The abbreviation used is: PP, protein serine/threonine phosphatase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1. Virshup, D. M. (2000) Curr. Opin. Cell Biol. 12, 180-185[CrossRef][Medline] [Order article via Infotrieve]
2. Janssens, V., and Goris, J. (2001) Biochem. J. 353, 417-439[CrossRef][Medline] [Order article via Infotrieve]
3. Ruediger, R., Van Wart Hood, J. E., Mumby, M., and Walter, G. (1991) Mol. Cell. Biol. 11, 4282-4285[Abstract/Free Full Text]
4. Lin, X. H., Walter, J., Scheidtmann, K., Ohst, K., Newport, J., and Walter, G. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 14693-14698[Abstract/Free Full Text]
5. Healy, A. M., Zolnierowicz, S., Stapleton, A. E., Goebl, M., DePaoli-Roach, A. A., and Pringle, J. R. (1991) Mol. Cell. Biol. 11, 5767-5780[Abstract/Free Full Text]
6. Mayer, R. E., Hendrix, P., Cron, P., Matthies, R., Stone, S. R., Goris, J., Merlevede, W., Hofsteenge, J., and Hemmings, B. A. (1991) Biochemistry 30, 3589-3597[CrossRef][Medline] [Order article via Infotrieve]
7. Pallas, D. C., Weller, W., Jaspers, S., Miller, T. B., Lane, W. S., and Roberts, T. M. (1992) J. Virol. 66, 886-893[Abstract/Free Full Text]
8. Zolnierowicz, S., Csortos, C., Bondor, J., Verin, A., Mumby, M. C., and DePaoli-Roach, A. A. (1994) Biochemistry 33, 11858-11867[CrossRef][Medline] [Order article via Infotrieve]
9. Strack, S., Chang, D., Zaucha, J. A., Colbran, R. J., and Wadzinski, B. E. (1999) FEBS Lett. 460, 462-466[CrossRef][Medline] [Order article via Infotrieve]
10. McCright, B., and Virshup, D. M. (1995) J. Biol. Chem. 270, 26123-26128[Abstract/Free Full Text]
11. McCright, B., Rivers, A. M., Audlin, S., and Virshup, D. M. (1996) J. Biol. Chem. 271, 22081-22089[Abstract/Free Full Text]
12. Csortos, C., Zolnierowicz, S., Bako, E., Durbin, S. D., and DePaoli-Roach, A. A. (1996) J. Biol. Chem. 271, 2578-2588[Abstract/Free Full Text]
13. Tanabe, O., Nagase, T., Murakami, T., Nozaki, H., Usui, H., Nishito, Y., Hayashi, H., Kagamiyama, H., and Takeda, M. (1996) FEBS Lett. 379, 107-111[CrossRef][Medline] [Order article via Infotrieve]
14. Tehrani, M. A., Mumby, M. C., and Kamibayashi, C. (1996) J. Biol. Chem. 271, 5164-5170[Abstract/Free Full Text]
15. Zolnierowicz, S., Van Hoof, C., Andjelkovic, N., Cron, P., Stevens, I., Merlevede, W., Goris, J., and Hemmings, B. A. (1996) Biochem. J. 317, 187-194[Medline] [Order article via Infotrieve]
16. Yan, Z., Fedorov, S. A., Mumby, M. C., and Williams, R. S. (2000) Mol. Cell. Biol. 20, 1021-1029[Abstract/Free Full Text]
17. Voorhoeve, P. M., Hijmans, E. M., and Bernards, R. (1999) Oncogene 18, 515-524[CrossRef][Medline] [Order article via Infotrieve]
18. Hendrix, P., Mayer-Jackel, R. E., Cron, P., Goris, J., Hofsteenge, J., Merlevede, W., and Hemmings, B. A. (1993) J. Biol. Chem. 268, 15267-15276[Abstract/Free Full Text]
19. Strack, S., Zaucha, J. A., Ebner, F. F., Colbran, R. J., and Wadzinski, B. E. (1998) J. Comp. Neurol. 392, 515-527[CrossRef][Medline] [Order article via Infotrieve]
20. Pallas, D. C., Shahrik, L. K., Martin, B. L., Jaspers, S., Miller, T. B., Brautigan, D. L., and Roberts, T. M. (1990) Cell 60, 167-176[CrossRef][Medline] [Order article via Infotrieve]
21. Walter, G., Ruediger, R., Slaughter, C., and Mumby, M. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 2521-2525[Abstract/Free Full Text]
22. Sontag, E., Fedorov, S., Kamibayashi, C., Robbins, D., Cobb, M., and Mumby, M. (1993) Cell 75, 887-897[CrossRef][Medline] [Order article via Infotrieve]
23. Moreno, C. S., Park, S., Nelson, K., Ashby, D., Hubalek, F., Lane, W. S., and Pallas, D. C. (2000) J. Biol. Chem. 275, 5257-5263[Abstract/Free Full Text]
24. Zhao, Y., Boguslawski, G., Zitomer, R. S., and DePaoli-Roach, A. A. (1997) J. Biol. Chem. 272, 8256-8262[Abstract/Free Full Text]
25. Silverstein, A. M., Barrow, C. A., Davis, A. J., and Mumby, M. C. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 4221-4226[Abstract/Free Full Text]
26. Turowski, P., Myles, T., Hemmings, B. A., Fernandez, A., and Lamb, N. J. (1999) Mol. Biol. Cell 10, 1997-2015[Abstract/Free Full Text]
27. Sontag, E., Nunbhakdi-Craig, V., Bloom, G. S., and Mumby, M. C. (1995) J. Cell Biol. 128, 1131-1144[Abstract/Free Full Text]
28. Sontag, E., Nunbhakdi-Craig, V., Lee, G., Bloom, G. S., and Mumby, M. C. (1996) Neuron 17, 1201-1207[CrossRef][Medline] [Order article via Infotrieve]
29. Hsu, W., Zeng, L., and Costantini, F. (1999) J. Biol. Chem. 274, 3439-3445[Abstract/Free Full Text]
30. Seeling, J. M., Miller, J. R., Gil, R., Moon, R. T., White, R., and Virshup, D. M. (1999) Science 283, 2089-2091[Abstract/Free Full Text]
31. Kleinberger, T. (2000) Apoptosis 5, 211-215[CrossRef][Medline] [Order article via Infotrieve]
32. Branton, P. E., and Roopchand, D. E. (2001) Oncogene 20, 7855-7865[CrossRef][Medline] [Order article via Infotrieve]
33. Kamibayashi, C., Estes, R., Lickteig, R. L., Yang, S. I., Craft, C., and Mumby, M. C. (1994) J. Biol. Chem. 269, 20139-20148[Abstract/Free Full Text]
34. Groves, M. R., Hanlon, N., Turowski, P., Hemmings, B. A., and Barford, D. (1999) Cell 96, 99-110[CrossRef][Medline] [Order article via Infotrieve]
35. Ruediger, R., Hentz, M., Fait, J., Mumby, M., and Walter, G. (1994) J. Virol. 68, 123-129[Abstract/Free Full Text]
36. Ruediger, R., Roeckel, D., Fait, J., Bergqvist, A., Magnusson, G., and Walter, G. (1992) Mol. Cell. Biol. 12, 4872-4882[Abstract/Free Full Text]
37. Egloff, M. P., Cohen, P. T., Reinemer, P., and Barford, D. (1995) J. Mol. Biol. 254, 942-959[CrossRef][Medline] [Order article via Infotrieve]
38. Goldberg, J., Huang, H. B., Kwon, Y. G., Greengard, P., Nairn, A. C., and Kuriyan, J. (1995) Nature 376, 745-753[CrossRef][Medline] [Order article via Infotrieve]
39. Kelley, L. A., MacCallum, R. M., and Sternberg, M. J. (2000) J. Mol. Biol. 299, 499-520[Medline] [Order article via Infotrieve]
40. Lambright, D. G., Sondek, J., Bohm, A., Skiba, N. P., Hamm, H. E., and Sigler, P. B. (1996) Nature 379, 311-319[CrossRef][Medline] [Order article via Infotrieve]
41. Guex, N., and Peitsch, M. C. (1997) Electrophoresis 18, 2714-2723[CrossRef][Medline] [Order article via Infotrieve]
42. Ruediger, R., Fields, K., and Walter, G. (1999) J. Virol. 73, 839-842[Abstract/Free Full Text]
43. Horowitz, M., Cepko, C. L., and Sharp, P. A. (1983) J. Mol. Appl. Genet. 2, 147-159[Medline] [Order article via Infotrieve]
44. Griswold-Prenner, I., Kamibayashi, C., Maruoka, E. M., Mumby, M. C., and Derynck, R. (1998) Mol. Cell. Biol. 18, 6595-6604[Abstract/Free Full Text]
45. Smith, T. F., Gaitatzes, C., Saxena, K., and Neer, E. J. (1999) Trends Biochem. Sci. 24, 181-185[CrossRef][Medline] [Order article via Infotrieve]
46. Robinson, R. C., Turbedsky, K., Kaiser, D. A., Marchand, J. B., Higgs, H. N., Choe, S., and Pollard, T. D. (2001) Science 294, 1679-1684[Abstract/Free Full Text]
47. Shi, J., Blundell, T. L., and Mizuguchi, K. (2001) J. Mol. Biol. 310, 243-257[CrossRef][Medline] [Order article via Infotrieve]
48. Li, X., and Virshup, D. M. (2002) Eur. J. Biochem. 269, 546-552[Medline] [Order article via Infotrieve]
49. Pittman, R. N., Wang, S., DiBenedetto, A. J., and Mills, J. C. (1993) J. Neurosci. 13, 3669-3680[Abstract]
50. Wu, J., Tolstykh, T., Lee, J., Boyd, K., Stock, J. B., and Broach, J. R. (2000) EMBO J. 19, 5672-5681[CrossRef][Medline] [Order article via Infotrieve]
51. Tolstykh, T., Lee, J., Vafai, S., and Stock, J. B. (2000) EMBO J. 19, 5682-5691[CrossRef][Medline] [Order article via Infotrieve]
52. Yu, X. X., Du, X., Moreno, C. S., Green, R. E., Ogris, E., Feng, Q., Chou, L., McQuoid, M. J., and Pallas, D. C. (2001) Mol. Biol. Cell 12, 185-199[Abstract/Free Full Text]
53. Wei, H., Ashby, D. G., Moreno, C. S., Ogris, E., Yeong, F. M., Corbett, A. H., and Pallas, D. C. (2001) J. Biol. Chem. 276, 1570-1577[Abstract/Free Full Text]
54. Bateman, A., Birney, E., Cerruti, L., Durbin, R., Etwiller, L., Eddy, S. R., Griffiths-Jones, S., Howe, K. L., Marshall, M., and Sonnhammer, E. L. (2002) Nucleic Acids Res. 30, 276-280[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
J. Batut, B. Schmierer, J. Cao, L. A. Raftery, C. S. Hill, and M. Howell
Two highly related regulatory subunits of PP2A exert opposite effects on TGF-{beta}/Activin/Nodal signalling
Development, September 1, 2008; 135(17): 2927 - 2937.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Kiely, G. S. Baillie, M. J. Lynch, M. D. Houslay, and R. O'Connor
Tyrosine 302 in RACK1 Is Essential for Insulin-like Growth Factor-I-mediated Competitive Binding of PP2A and {beta}1 Integrin and for Tumor Cell Proliferation and Migration
J. Biol. Chem., August 22, 2008; 283(34): 22952 - 22961.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Xia, R. Nho, J. Kleidon, J. Kahm, and C. A. Henke
Polymerized Collagen Inhibits Fibroblast Proliferation via a Mechanism Involving the Formation of a {beta}1 Integrin-Protein Phosphatase 2A-Tuberous Sclerosis Complex 2 Complex That Suppresses S6K1 Activity
J. Biol. Chem., July 18, 2008; 283(29): 20350 - 20360.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Davis, Z. Yan, B. Martinez, and M. C. Mumby
Protein Phosphatase 2A Is Targeted to Cell Division Control Protein 6 by a Calcium-binding Regulatory Subunit
J. Biol. Chem., June 6, 2008; 283(23): 16104 - 16114.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Longin, K. Zwaenepoel, J. V. Louis, S. Dilworth, J. Goris, and V. Janssens
Selection of Protein Phosphatase 2A Regulatory Subunits Is Mediated by the C Terminus of the Catalytic Subunit
J. Biol. Chem., September 14, 2007; 282(37): 26971 - 26980.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
V. Horn, J. Thelu, A. Garcia, C. Albiges-Rizo, M. R. Block, and J. Viallet
Functional Interaction of Aurora-A and PP2A during Mitosis
Mol. Biol. Cell, April 1, 2007; 18(4): 1233 - 1241.
[Abstract] [Full Text] [PDF]